The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Cytokine imbalance in the pathophysiology of major depressive disorder
Open accessAbstract
OBJECTIVE A substantial body of evidence indicates that dysregulation of the immune system is associated with Major Depressive Disorder (MDD). Because most cytokines have pleiotropic effects, we measured various subsets of cytokines to examine the association between immune response and MDD. METHODS Forty-eight hospitalized MDD patients and 63 normal controls were recruited. We measured in vitro monocytic (IL-6 and tumor necrosis factor (TNF)-alpha), Th1 (interferon (IFN)-gamma and interleukin (IL)-2), Th2 (IL-4), and Treg (transforming growth factor (TGF)-beta1) cytokine production as well as IL-2/IL-4 and IFN-gamma/IL-4 ratios for both groups. Depressive symptoms were assessed by Hamilton Depression Rating Scale. Patients were evaluated before and after 6 weeks of antidepressant treatment. RESULTS At admission, IL-6, TNF-alpha, TGF-beta1 production, and IFN-gamma/IL-4 ratio were significantly higher, whereas IFN-gamma, IL-2, and IL-4 were significantly lower in MDD patients. After treatment, IL-6 and TGF-beta1 production were significantly lower than before treatment. CONCLUSION We suggest that activation of monocytic proinflammatory cytokines, and inhibition of both Th1 and Th2 cytokines may be associated with immunological dysregulation in MDD. TGF-beta1 may be associated with the regulation of monocytic cytokines as well as Th1 and Th2 cytokines in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235 · cited 1×
“A growing body of evidence suggests that dysregulation of the immune system, including the cytokine network, is associated with the etiology and pathophysiology of major depressive disorder (MDD) (Maes et al., 1990; Kenis and Maes, 2002; Kronfol, 2002; Myint and Kim, 2003; Schiepers et al., 2005).”
BackgroundMaier, S. F., & Watkins, L. R. (1998) · Psychological Review · doi:10.1037/0033-295x.105.1.83 · Cited by 1,130 · cited 1×
“…are associated with MDD. Firstly, patients and animals administered IL-2 and IFN-α experienced ‘sickness behaviors’ that resembled depression: insomnia, decreased appetite, loss of interest, and fatigue (Maier and Watkins, 1998; Capuron et al., 2000; Bonaccorso et al., 2002; Larson et al., 2002).”
BackgroundEvidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Depression and immunity: A meta-analytic review.
Herbert, T. B., & Cohen, S. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.113.3.472 · Cited by 803
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784 · cited 1×
“Peripheral cytokines can communicate with brain cells by various mechanisms (Watkins et al., 1995; Kronfol and Remick, 2000; Banks, 2005).”
BackgroundTaylor, A., Verhagen, J., Blaser, K., Akdis, M., & Akdis, C. A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02321.x · Cited by 720
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Clinical Relevance of Age-Related Immune Dysfunction
Castle, S. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313947 · Cited by 640
Depression in Rheumatoid Arthritis: A Systematic Review of the Literature With Meta-Analysis
Dickens, C., McGowan, L., Clark-Carter, D., & Creed, F. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200201000-00008 · Cited by 634
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617 · cited 2×
“Au th or 's pe rs on al co py inflammatory reactions (Maes, 1999; Rothermundt et al., 2001; Kim et al., 2002) and diminished cellular immune competence (Irwin, 2002; Pike and Irwin, 2006).”
BackgroundResultCytokine-to-brain communication: A review & analysis of alternative mechanisms
Watkins, L. R., Maier, S. F., & Goehler, L. E. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02047-m · Cited by 597
Blood-brain barrier transport of cytokines: a mechanism for neuropathology
Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534
Mechanism of Transforming Growth Factor β–induced Inhibition of T Helper Type 1 Differentiation
Gorelik, L., Constant, S., & Flavell, R. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012076 · Cited by 521
Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone
Beagley, K. W., & Gockel, C. M. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00202-5 · Cited by 484
De Groote, D., Zangerle, P. F., Gevaert, Y., Fassotte, M. F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez, M., Dehart, I., et al. (1992) · Cytokine · doi:10.1016/1043-4666(92)90062-v · Cited by 470
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity
Cutolo, M., Sulli, A., Capellino, S., Villaggio, B., Montagna, P., Seriolo, B., & Straub, R. H. (2004) · Lupus · doi:10.1191/0961203304lu1094oa · Cited by 407
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., & Thorbecke, G. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2918 · Cited by 399
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Self-citationTh1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 3×
“, 1997) and MDD (Myint et al., 2005; Lee and Kim, 2006).”
BackgroundInfluentialSelf-citationEffects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
The immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6
Lin, A., Kenis, G., Bignotti, S., Tura, G.-J.-B., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., & Maes, M. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00034-6 · Cited by 321
Xia, Z., Depierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318
Mood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Capuron, L., Ravaud, A., & Dantzer, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2143 · Cited by 294
Prior Stressor Exposure Sensitizes LPS-Induced Cytokine Production
Johnson, J. D., O'Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0638 · Cited by 270
Higgins, S. C., Lavelle, E. C., McCann, C., Keogh, B., McNeela, E., Byrne, P., O’Gorman, B., Jarnicki, A., McGuirk, P., & Mills, K. H. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3119 · Cited by 265
Stress Responsive Neurohormones in Depression and Anxiety
(2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45132 · Cited by 264
Cytokine Dysregulation Associated with Exam Stress in Healthy Medical Students
Marshall, G. D., Agarwal, S. K., Lloyd, C., Cohen, L., Henninger, E. M., & Morris, G. J. (1998) · Brain, Behavior, and Immunity · doi:10.1006/brbi.1998.0537 · Cited by 258
DeRijk, R., Michelson, D., Karp, B., Petrides, J., Galliven, E., Deuster, P., Paciotti, G., Gold, P. W., & Sternberg, E. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4041 · Cited by 250
Regulation of NK cell functions by TGF-β 1
Bellone, G., Aste-Amezaga, M., Trinchieri, G., & Rodeck, U. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1066 · Cited by 243
Bonaccorso, S., Puzella, A., Marino, V., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Levrero, M., Egyed, B., Bosmans, E., et al. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00315-8 · Cited by 236
Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224 · cited 2×
“Kim et al. / Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 1044–1053”
BackgroundSelf-citationCapuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00030-0 · Cited by 201
Immune Disturbances during Major Depression: Upregulated Expression of Interleukin-2 Receptors
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., De Jonckheere, C., & Raus, J. (2008) · Neuropsychobiology · doi:10.1159/000119472 · Cited by 200
Kaestner, F., Hettich, M., Peters, M., Sibrowski, W., Hetzel, G., Ponath, G., Arolt, V., Cassens, U., & Rothermundt, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.012 · Cited by 176
Inflammatory markers in major depression and melancholia.
Rothermundt, M., Arolt, V., Peters, M., Gutbrodt, H., Fenker, J., Kersting, A., & Kirchner, H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00157-9 · Cited by 174
Paroxetine for the treatment of interferon‐α‐induced depression in chronic hepatitis C
Kraus, M. R., Schäfer, A., Faller, H., Csef, H., & Scheurlen, M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01265.x · Cited by 170
Psychoneuroimmunology of depression: clinical implications
Irwin, M. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0654 · Cited by 160
Pathways Linking Major Depression and Immunity in Ambulatory Female Patients
Miller, G. E., Cohen, S., & Herbert, T. B. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199911000-00021 · Cited by 157
Macrophage Production of TGF‐β and Regulation by TGF‐β
Wahl, S. M., McCartney-Francis, N. L., Allen, J. B., Dougherty, E., & Dougherty, S. F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16111.x · Cited by 156
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Self-citationGENETIC DETERMINANTS INFLUENCING THE RESPONSE TO INJURY, INFLAMMATION, AND SEPSIS
Maio, A. D., Torres, M. B., & Reeves, R. H. (2004) · Shock · doi:10.1097/01.shk.0000144134.03598.c5 · Cited by 143
Konan, K. V., & Taylor, M. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19140 · Cited by 121
Cytokine profiles in women with different subtypes of major depressive disorder
Marques-Deak, A., NETO, F., Dominguez, W. V., Solis, A. C. D. O., Kurcgant, D., Sato, F. P., Ross, J. M., & Prado, E. D. F. G. B. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.11.003 · Cited by 120
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115 · cited 1×
“A recent animal study suggested that tricyclic antidepressants inhibit monocytic proinflammatory cytokine release in microglial cell cultures (Obuchowicz et al., 2006).”
BackgroundThe role of the cytokine network in psychological stress
Kim, Y., & Maes, M. H. J. (2003) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2003.00026.x · Cited by 112
Self-citationImmune activation and depression in women with rheumatoid arthritis.
Zautra, A., Yocum, D., Villanueva, I., Smith, B. W., Davis, M. C., Attrep, J. F., & Irwin, M. R. (2004) · PubMed · Cited by 107
Gender differences in the development and function of the immune system
Shames, R. S. (2002) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00382-2 · Cited by 107
Interleukin-1β and tumor necrosis factor-α in children with major depressive disorder or dysthymia
Brambilla, F., Monteleone, P., & Maj, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00315-4 · Cited by 107
Sertraline treatment of interferon‐alfa‐induced depressive disorder
Schramm, T. M., Lawford, B. R., Cooksley, W. G. E., & Macdonald, G. A. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb125687.x · Cited by 104
Rider, V., & Abdou, N. I. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00046-7 · Cited by 104
Elevated circulating levels of IL-6 in schizophrenia
Naudin, J., Mège, J. L., Azorin, J., & Dassa, D. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00014-x · Cited by 104
Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder
Pike, J. L., & Irwin, M. R. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.05.004 · Cited by 101
Kubera, M., Kenis, G., Bosmans, E., Scharpé, S., & Maes, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00150-5 · Cited by 100
Immune dysregulation in major depression: a critical review of existing evidence
Kronfol, Z. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003024 · Cited by 100
Guillemin, G. J., Kerr, S. J., Pemberton, L. A., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, B. J. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001317205231 · Cited by 95
Young, M. R., Kut, J. L., Coogan, M. P., Wright, M. A., Young, M. E., & Matthews, J. (1993) · PubMed Central · Cited by 93
Modulation of serotonin transporter function by interleukin-4
Mößner, R., Daniel, S., Schmitt, A. G., Albert, D., & Lesch, K. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00992-9 · Cited by 86
Wichers, M., Kenis, G., Leue, C., Koek, G. H., Robaeys, G., & Maes, M. H. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.024 · Cited by 85
West, D. V., & Maes, M. H. J. (1999) · PubMed · Cited by 84
Connor, T. J., Harkin, A., Kelly, J. P., & Leonard, B. E. (1999) · NeuroImmunoModulation · doi:10.1159/000026417 · Cited by 81
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
DeRijk, R. H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2182 · Cited by 77
Cyranowski, J. M., Marsland, A. L., Bromberger, J. T., Whiteside, T. L., Chang, Y., & Matthews, K. A. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.07.005 · Cited by 73
Effects of Interleukin-1β on Food-Maintained Behavior in the Mouse
Larson, S. J., Romanoff, R. L., Dunn, A. J., & Glowa, J. R. (2002) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0634 · Cited by 68
Ha, E., Jung, K. H., Choe, B., Bae, J., Shin, D.-H., Yim, S., & Baik, H. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.022 · Cited by 58
Role of Serotonin in the Regulation of Interferon-γ Production by Human Natural Killer Cells
Hellstrand, K., Czerkinsky, C. C., Ricksten, A., JANSSON, B., Asea, A. A. A., Kylefjord, H., & Hermodsson, S. (1993) · Journal of Interferon Research · doi:10.1089/jir.1993.13.33 · Cited by 54
Latent Forms of TGF‐β: Structure and Biology
Miyazono, K., Yuki, K., Takaku, F., Wernstedt, C., Kanzaki, T., OLOFSSON, A., Hellman, U., & Heldin, C. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16099.x · Cited by 53
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus
Ferro, D., Basili, S., Roccaforte, S., Franco, M. D., Cipollone, F., Ciabattoni, G., & Dav�, G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2561::aid-anr8>3.0.co;2-u · Cited by 36
Transforming Growth Factors β1 and β2 in the Cerebrospinal Fluid of Chronic Schizophrenic Patients
Vawter, M. P. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00143-1 · Cited by 26
Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression
Levitan, R. D., Kaplan, A. S., Brown, G. M., Joffe, R. T., LEVITT, A. J., Vaccarino, F. J., & Kennedy, S. H. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00432-5 · Cited by 21
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Metadata
- Authors
- Kim, Y.-K., Na, K.-S., Shin, K.-H., Jung, H.-Y., Choi, S.-H., & Kim, J.-B.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 31
- Issue
- 5
- Pages
- 1044-1053
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2024448645
- Cited by
- 314
- References
- 83
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.